Ropivacaine

Generic Name
Ropivacaine
Brand Names
Naropin
Drug Type
Small Molecule
Chemical Formula
C17H26N2O
CAS Number
84057-95-4
Unique Ingredient Identifier
7IO5LYA57N
Background

Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.

Indication

Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.

Associated Conditions
Acute Pain, Postoperative pain
Associated Therapies
Surgical anesthesia therapy

Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty

First Posted Date
2016-10-14
Last Posted Date
2022-07-19
Lead Sponsor
Duke University
Target Recruit Count
11
Registration Number
NCT02933671
Locations
🇺🇸

Duke University Hospital, Durham, North Carolina, United States

Comparing Ropivacaine and Bupivacaine in DTFNB Anesthesia in Patients Undergoing Phacoemulsification

First Posted Date
2016-10-06
Last Posted Date
2017-01-25
Lead Sponsor
Government Medical College, Haldwani
Target Recruit Count
100
Registration Number
NCT02925832
Locations
🇮🇳

Government medical college, Haldwani, Uttarakhand, India

Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients

First Posted Date
2016-10-05
Last Posted Date
2022-11-08
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
56
Registration Number
NCT02924324
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Chloroprocaine 3% - Epidural Anesthesia in Unplanned Caesarean Section

First Posted Date
2016-09-29
Last Posted Date
2023-11-21
Lead Sponsor
Sintetica SA
Target Recruit Count
16
Registration Number
NCT02919072
Locations
🇧🇪

UZ Leuven, campus Gasthuisberg, Leuven, Belgium

Continous Quadratus Lumborum Block for Hepatic Surgery With Right Subcostal Incision

First Posted Date
2016-09-26
Last Posted Date
2019-09-04
Lead Sponsor
Cui Xulei
Target Recruit Count
40
Registration Number
NCT02914015
Locations
🇨🇳

Xulei CUI, Beijing, Beijing, China

The Effect of Phrenic Nerve Block on Postoperative Shoulder Pain in Patients for Liver Resection.

First Posted Date
2016-09-16
Last Posted Date
2016-09-23
Lead Sponsor
Eske Kvanner Aasvang
Target Recruit Count
30
Registration Number
NCT02903719
Locations
🇩🇰

Rigshospitalet, Copenhagen, Denmark

Ropivacaine Transversus Abdominis Plane Blocks for Cesarean Section Analgesia

Not Applicable
Terminated
Conditions
Interventions
First Posted Date
2016-09-08
Last Posted Date
2022-09-21
Lead Sponsor
Maimonides Medical Center
Target Recruit Count
51
Registration Number
NCT02893423
Locations
🇺🇸

Maimonides Medical Center, Brooklyn, New York, United States

Comparison of Programmed Intermittent Epidural Bolus With Continuous Epidural Infusion for Labor Epidural Analgesia

First Posted Date
2016-08-19
Last Posted Date
2016-12-28
Lead Sponsor
Nanjing Maternity and Child Health Care Hospital
Target Recruit Count
186
Registration Number
NCT02873091
Locations
🇨🇳

Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu, China

Ultrasound-guided Thoracic Paravertebral Block Using Ropivacaine With/Without Dexamethasone in Elective Thoracotomy

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2016-08-18
Last Posted Date
2017-02-09
Lead Sponsor
The First Affiliated Hospital of Anhui Medical University
Target Recruit Count
68
Registration Number
NCT02871193
Locations
🇨🇳

The first affiliated hospital of Anhui Medical University, Hefei, Anhui, China

Liposomal Bupivacaine vs Adductor Canal Block in Total Knee Arthroplasty

First Posted Date
2016-08-11
Last Posted Date
2020-10-08
Lead Sponsor
Texas Orthopaedics, Sports and Rehabilitation Associates
Target Recruit Count
63
Registration Number
NCT02863120
Locations
🇺🇸

Texas Orthopedics, Austin, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath